Articles by Eric B. Sheinin, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric B. Sheinin, PhD

Eric B. Sheinin, PhD


Eric Sheinin is the president of Sheinin and Associates, 13917 Bergenfield Dr., North Potomac, MD 20878, tel. 301.424.2606, fax 301.424.2831. He also is a member of Pharmaceutical Technologys editorial advisory board.

Articles
A Dubious Foundation for Quality Control
August 2, 2009

The author of an ambitious book about quality control falls short of reaching his goals.

USP's Semi-Hemiquinquennial Meeting
June 2, 2004

A recent USP gathering generated creative suggestions for the March 2005 USP convocation.

"A State of Revision: USP's Guideline for the Submission of Requests for Revision"
December 2, 2003

USP's new guideline will assist the industry to help set the monograph standards by which the industry must abide. This column suggests how to apply the guideline to gain maximum benefit.

Reflections on Changes at FDA
July 1, 2001

A former deputy director of the Office of Pharmaceutical Sciences takes a personal look back at 25 years of change at FDA's Center for Drug Evaluation and Research.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here